MARKET

HCM

HCM

Chi-Med
NASDAQ

Real-time Quotes | Nasdaq Last Sale

29.41
+0.41
+1.41%
After Hours: 29.41 0 0.00% 16:00 01/17 EST
OPEN
29.03
PREV CLOSE
29.00
HIGH
29.47
LOW
28.65
VOLUME
199.02K
TURNOVER
--
52 WEEK HIGH
32.55
52 WEEK LOW
16.47
MARKET CAP
3.92B
P/E (TTM)
-446.9605
1D
5D
1M
3M
1Y
5Y

Buy or sell shares of HCM and other stocks commission-free!

Open a Webull account and fund it to get a free stock

Analyst Rating

Based on 7 analysts

Buy

Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.

EPS

HCM News

  • Hutchison China MediTech (HCM) Is Up 0.6% in One Week: What You Should Know
  • Zacks.2d ago
  • Chi-Med Initiates a Phase II Trial of Surufatinib in Combination with Tuoyi in Patients with Advanced Solid Tumors
  • GlobeNewswire.5d ago
  • Chi-Med to Present at the 38th Annual JP Morgan Healthcare Conference
  • GlobeNewswire.01/06 07:50
  • Chi-Med’s Surufatinib nabs accelerated review in China for non-pancreatic NET
  • Seeking Alpha - Article.12/20/2019 11:55

More

Industry

Pharmaceuticals
+0.13%
Pharmaceuticals & Medical Research
+0.06%

Hot Stocks

Name
Price
%Change

About HCM

Hutchison China Meditech Limited is an investment holding company principally engaged in the manufacture and sale of drugs. Along with subsidiaries, the Company operates its business through two segments. The Manufacturing Business segment is engaged in the manufacture and distribution of drug products. The Distribution Business segment provides sales and marketing services to pharmaceutical manufacturers. The Company's products include prescription and over the counter (OTC) pharmaceuticals such as banlangen, fu fang dan shen tablets and shexiang baoxin pills and others, and consumer health products. In addition, the Company also develops targeted therapeutics and immunotherapies for oncology and autoimmune diseases.
More

Webull offers Hutchison China MediTech Limited (HCM) stock price, real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, stock news, and many more online research tools to help you make informed decisions.